References
- Han B, Compton WM, Blanco C, et al. Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 national survey on drug use and health. Ann Intern Med. 2017;167:293–301.
- Epstein RA, Bobo WV, Martin PR, et al. Increasing pregnancy-related use of prescribed opioid analgesics. Ann Epidemiol. 2013;23:498–503.
- Desai RJ, Hernandez-Diaz S, Bateman BT, et al. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstet Gynecol. 2014;123:997–1002.
- Patrick SW, Schumacher RE, Benneyworth BD, et al. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA. 2012;307:1934–1940.
- Villapiano NL, Winkelman TN, Kozhimannil KB, et al. Rural and urban differences in neonatal abstinence syndrome and maternal opioid use, 2004 to 2013. JAMA pediatrics. 2017;171:194–196.
- Krans EE, Patrick SW. Opioid use disorder in pregnancy: Health policy and practice in the midst of an epidemic. Obstet Gynecol. 2016;128:4–10.
- Maryland Maternal Mortality Review 2016 Annual Report. Annapolis, Maryland: Maryland Department of Health and Mental Hygiene Prevention and Health Promotion Administration 2016.
- Ko JY, Patrick SW, Tong VT, et al. Incidence of neonatal abstinence syndrome - 28 States, 1999-2013. MMWR Morb Mortal Wkly Rep. 2016;65:799–802.
- Tolia VN, Patrick SW, Bennett MM, et al. Increasing incidence of the neonatal abstinence syndrome in U.S. Neonatal ICUs. N Engl J Med. 2015;372:2118–2126.
- Patrick SW, Davis MM, Lehmann CU, et al. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015;35:650–655.
- ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy. Obstet Gynecol. 2012;119:1070–1076.
- Fullerton CA, Kim M, Thomas CP, et al. Medication-assisted treatment with methadone: assessing the evidence. Psychiatr Serv. 2014;65:146–157.
- Sees KL, Delucchi KL, Masson C, et al. Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. Jama. 2000;283:1303–1310.
- McCarthy JJ, Leamon MH, Parr MS, et al. High-dose methadone maintenance in pregnancy: maternal and neonatal outcomes. Am J Obstet Gynecol. 2005;193:606–610.
- Schwartz RP, Kelly SM, O'Grady KE, et al. Interim methadone treatment compared to standard methadone treatment: 4-month findings. Journal of substance abuse treatment. 2011;41:21–29.
- Schwartz RP, Kelly SM, O'Grady KE, et al. Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings. Addiction. 2012;107:943–952.
- Wilson ME, Schwartz RP, O'Grady KE, et al. Impact of interim methadone maintenance on HIV risk behaviors. Journal of urban health: bulletin of the New York Academy of Medicine. 2010;87:586–591.
- Schwartz RP, Gryczynski J, O'Grady KE, et al. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009. Am J Public Health. 2013;103:917–922.
- Kandall SR, Albin S, Lowinson J, et al. Differential effects of maternal heroin and methadone use on birthweight. Pediatrics. 1976;58:681–685.
- Curda EH. Opioid Addiction: Laws, Regulations and Other Factors can Affect Medication-Assisted Treatment Access. Washington, D.C.: Government Accountability Office; 2016.
- Crisis TPsCoCDAatO. Final Report. Washington, D.C.: Executive Office of the President, The White House; 2017.
- Hirchak KA, Murphy SM. Assessing differences in the availability of opioid addiction therapy options: rural versus Urban and American Indian Reservation versus nonreservation. The Journal of rural health: official journal of the American Rural Health Association and the National Rural Health Care Association. 2017;33:102–109.
- Martin CE, Longinaker N, Terplan M. Recent trends in treatment admissions for prescription opioid abuse during pregnancy. Journal of substance abuse treatment. 2015;48:37–42.
- Guy GP, Jr., Zhang K, Bohm MK, et al. Vital signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66:697–704.
- Number and age-adjusted rates of drug overdose deaths by state, US 2015. 2017; https://www.cdc.gov/drugoverdose/data/statedeaths.html.AccessedJune16,2017.
- Rudd RA, Aleshire N, Zibbell JE, et al. Increases in drug and opioid overdose deaths–United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64:1378–1382.
- Patrick SW, Bauer AM, Warren MD, et al. Hepatitis C virus infection among women giving birth - Tennessee and United States, 2009-2014. MMWR Morb Mortal Wkly Rep. 2017;66:470–473.
- Parran TV, Muller JZ, Chernyak E, et al. Access to and payment for office-based buprenorphine treatment in Ohio. Substance abuse: research and treatment. 2017;11:1178221817699247.
- Patrick SW, Dudley J, Martin PR, et al. Prescription opioid epidemic and infant outcomes. Pediatrics. 2015;135:842–850.
- Committee Opinion No. 711: Opioid Use and Opioid Use Disorder in Pregnancy. Obstet Gynecol. 2017;130:e81–e94.
- Prevention CfDCa. Prescription Opioid Overdose Data. 2016; http://www.cdc.gov/drugoverdose/data/overdose.html.AccessedDecember5,2016.
- Meyer MC, Johnston AM, Crocker AM, et al. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study. J Addict Med. 2015;9:81–86.
- Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363:2320–2331.
- Substance Use During Pregnancy. 2018; https://www.guttmacher.org/state-policy/explore/substance-use-during-pregnancy. Accessed March 8, 2018.